Squarepoint Ops LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$401,171
-14.8%
14,551
-7.1%
0.00%0.0%
Q2 2023$470,589
+4.3%
15,655
+25.7%
0.00%
-50.0%
Q1 2023$451,281
-60.9%
12,456
-61.5%
0.00%
-60.0%
Q4 2022$1,153,710
-16.6%
32,344
-20.8%
0.01%
-28.6%
Q3 2022$1,383,000
+210.1%
40,842
+196.3%
0.01%
+250.0%
Q1 2022$446,000
-55.1%
13,785
-59.6%
0.00%
-33.3%
Q4 2021$994,000
+66.8%
34,092
+49.8%
0.00%0.0%
Q1 2021$596,000
+68.4%
22,764
+62.0%
0.00%0.0%
Q4 2020$354,000
-54.3%
14,055
-62.2%
0.00%
-70.0%
Q3 2020$775,000
-47.1%
37,187
-39.8%
0.01%
-58.3%
Q2 2020$1,466,000
+35.6%
61,731
+2.7%
0.02%
-14.3%
Q1 2020$1,081,000
-48.8%
60,108
-32.5%
0.03%
+115.4%
Q4 2019$2,112,000
+55.4%
89,031
+80.0%
0.01%
+8.3%
Q3 2019$1,359,000
+256.7%
49,452
+329.1%
0.01%
+200.0%
Q2 2019$381,000
-82.5%
11,524
-81.5%
0.00%
-82.6%
Q1 2019$2,178,000
+258.2%
62,145
+239.6%
0.02%
+228.6%
Q4 2018$608,000
-30.8%
18,302
+5.0%
0.01%
-36.4%
Q3 2018$878,000
-66.1%
17,436
-69.2%
0.01%
-73.2%
Q1 2018$2,591,000
+589.1%
56,569
+498.8%
0.04%
+485.7%
Q4 2017$376,000
-82.0%
9,447
-81.9%
0.01%
-82.5%
Q3 2017$2,087,000
+4.6%
52,176
+12.7%
0.04%
+2.6%
Q2 2017$1,996,000
+47.7%
46,307
+7.3%
0.04%
+5.4%
Q1 2017$1,351,000
+61.8%
43,151
+30.4%
0.04%
+8.8%
Q4 2016$835,000
+245.0%
33,086
+178.9%
0.03%
+126.7%
Q2 2016$242,000
-36.5%
11,861
-52.5%
0.02%
-50.0%
Q1 2016$381,000
-0.5%
24,994
-12.3%
0.03%
-28.6%
Q4 2015$383,00028,4940.04%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders